7 Endometriosis Headlines You Can’t Miss


6. Valirx Planning Endometriosis Clinical Test of its Anti-Cell Growth Candidate, VAL201

endometriosis study

Valirx plc, a London-based biopharmaceutical company specializing in oncology therapeutics and diagnostics with a particular focus on cancer treatments and associated biomarkers, is conducting a Phase 1/2 clinical trial of its drug candidate VAL201 on people with hormone-resistant prostate cancer. But the company may soon expand its VAL201 research to endometriosis.

Read more about it: http://bit.ly/1SgeCIC

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *